David Young - Aug 5, 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Aug 5, 2021
Transactions value $
$0
Form type
4
Date filed
8/9/2021, 04:33 PM
Previous filing
Jul 9, 2021
Next filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award +7.6K +2.03% 382K Aug 5, 2021 Direct F1
holding PCSA Common Stock 574K Aug 5, 2021 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 695K Aug 5, 2021 By Family Entities
holding PCSA Common Stock 37.5K Aug 5, 2021 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.